Isis Pharmaceuticals, Inc. (ISIS) Higher After Tops Q2 EPS by 9c

Article Stock Quotes (1) Comments (0)

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) are trading higher after the company reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $40.06 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
• John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
• Crown Crafts, Inc. (CRWS) Posts Flat Q4 EPS of 19c

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?